mva-hlinsmut
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 4, 2017 (NCT03688061)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis C virusImmunity, active
Hepatitis C virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03688061 | Phase 1 | Dec 4, 2017 | European Commission, GlaxoSmithKline, ReiThera Srl, University of Oxford |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Commission | Government | 1 | 0 | 1 | 2017 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2017 |
| ReiThera Srl | For profit | 1 | 0 | 1 | 2017 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1